PureTech Health (NASDAQ:PRTC) Shares Gap Up to $20.69

PureTech Health plc (NASDAQ:PRTC)’s share price gapped up before the market opened on Friday . The stock had previously closed at $20.69, but opened at $21.63. PureTech Health shares last traded at $21.25, with a volume of 9,730 shares changing hands.

Wall Street Analyst Weigh In

Several research analysts have commented on PRTC shares. Leerink Partners began coverage on shares of PureTech Health in a report on Monday, September 9th. They issued an “outperform” rating and a $45.00 price objective for the company. Leerink Partnrs raised shares of PureTech Health to a “strong-buy” rating in a research note on Monday, September 9th.

PureTech Health Price Performance

The stock has a 50 day moving average price of $21.55 and a 200 day moving average price of $25.23.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. acquired a new position in PureTech Health plc (NASDAQ:PRTC) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 6,900 shares of the company’s stock, valued at approximately $197,000. Institutional investors own 0.04% of the company’s stock.

About PureTech Health

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.